Announcement
2
REGULATORY TOXICOLOGY AND PHARMACOLOGY l&92-93 (1989) ANNOUNCEMENT International Society of Regulatory Toxicology and Pharmacology Fifth Annual Meeting An Agenda for Improving Regulatory Progress Washington Marriott Hotel, 1221 22nd Street, NW, Washington, D.C. 20037, October 2-3, 1989 The basic theme of this meeting is to examine the trends in recent years of a more centralized control of Federal regulation by the executive branch of the United States Government and the successes and shortfalls in regulatory reform measures in the areas of health and safety. An authoritative group of speakers formerly or currently with Federal and State Governments will be featured along with the views of highly regarded outside observers. The recent national turbulent commotion that arose following the publicity of a highly emotional and unnecessarily alarming report of an unacceptable cancer risk in children caused by an apple growth regulator is cause for the scientific community to correct this misinformation. Public announcements of this character require prior unbiased review in accordance with acceptable standards based on factual knowl- edge. The Society’s preeminence is established as a forum to explore difficult toxico- logical issues of this kind by stimulating interdisciplinary discussions among scien- tists, lawyers, and government officials who deal with regulatory philosophy and the ethical dimensions of acceptable risk. As in the past, this meeting will emphasize that the important contribution to resolving regulatory problems is to be made by accepting the well-recognized concept of de minimis and not to adhere rigidly to a zero-level for regulating presumed toxic substances. Unfortunately, regulatory decisions including national criteria for toxicologic is- sues are more often the pliable outcome of political accommodations of many inter- ests. To achieve the Society’s goal will require effective communication to the public, the news media, and Congress. To this end it is planned to include discussions of such key questions as: Will the states continue to promulgate regulations and set standards stricter than the Federal Government? Is biomedical research actually help- 92 Copyright 0 1989 by Academic Press, Inc. All rights of reproduction in any form reserved
Transcript of Announcement
REGULATORY TOXICOLOGY AND PHARMACOLOGY l&92-93 (1989)
ANNOUNCEMENT
International Society of Regulatory Toxicology and Pharmacology Fifth Annual Meeting
An Agenda for Improving Regulatory Progress
Washington Marriott Hotel, 1221 22nd Street, NW, Washington, D.C. 20037, October 2-3, 1989
The basic theme of this meeting is to examine the trends in recent years of a more centralized control of Federal regulation by the executive branch of the United States Government and the successes and shortfalls in regulatory reform measures in the areas of health and safety. An authoritative group of speakers formerly or currently with Federal and State Governments will be featured along with the views of highly regarded outside observers.
The recent national turbulent commotion that arose following the publicity of a highly emotional and unnecessarily alarming report of an unacceptable cancer risk in children caused by an apple growth regulator is cause for the scientific community to correct this misinformation. Public announcements of this character require prior unbiased review in accordance with acceptable standards based on factual knowl- edge. The Society’s preeminence is established as a forum to explore difficult toxico- logical issues of this kind by stimulating interdisciplinary discussions among scien- tists, lawyers, and government officials who deal with regulatory philosophy and the ethical dimensions of acceptable risk. As in the past, this meeting will emphasize that the important contribution to resolving regulatory problems is to be made by accepting the well-recognized concept of de minimis and not to adhere rigidly to a zero-level for regulating presumed toxic substances.
Unfortunately, regulatory decisions including national criteria for toxicologic is- sues are more often the pliable outcome of political accommodations of many inter- ests. To achieve the Society’s goal will require effective communication to the public, the news media, and Congress. To this end it is planned to include discussions of such key questions as: Will the states continue to promulgate regulations and set standards stricter than the Federal Government? Is biomedical research actually help-
92
Copyright 0 1989 by Academic Press, Inc. All rights of reproduction in any form reserved
ANNOUNCEMENT 93
ing to improve the way regulatory agenices approach the health, safety, and the envi- ronmental arena?
Additional information and programs can be obtained from:
C. Jelleff Can-, Ph.D., Secretary 6546 Belleview Drive Columbia, Maryland 2 1046 Telephone: (301) 992-9083
Early registration is suggested as total attendance is limited.
